Navigation Links
Knome Announces KnomeDISCOVERY Research Awards Program
Date:4/28/2010

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Knome today announced the launch of its KnomeDISCOVERY Research Awards Program.  Given annually, the awards will fund innovative research projects that help reveal the genetic underpinnings of diseases and other important human traits. To inaugurate the program, Knome will award its exome sequencing and interpretation services to three winning research groups, each of which will study a pair of human exomes in order to answer a compelling biological question.  

Founded by Harvard geneticist George Church and led by internationally recognized scientists, clinicians, and bioinformaticians, Knome provides cutting-edge genome sequencing and interpretation services for biomedical researchers and families seeking to understand the causes of human disease.

"Genome sequence analysis is revolutionizing biomedical research.  My hope is that these awards will ignite researchers' imaginations," said George Church, Ph.D., Co-Founder & Chief Scientific Advisor of Knome. "Many experts in human disease stand to gain remarkable insights from exome sequencing, but could use guidance in interpreting the vast amount of data involved. Knome's sequence interpretation services can help such scientists play driving roles in the genomic revolution."

The company invites researchers to submit proposals before June 15, 2010; winners will be announced on July 30, 2010.  A panel of scientific advisors, led by George Church, will judge proposals on scientific merit, feasibility, and funding need.  Please see www.knome.com/awards for more information.

About Knome

Human genomics for disease investigation

Based in Cambridge, Mass., Knome is a leading human genomics company focused on providing secure, state-of-the-art sequencing and analysis solutions for biomedical researchers and motivated families that seek to understand the genetic underpinnings of disease. Led by internationally recognized geneticists, clinicians, and bioinformaticians, Knome is responsible for sequencing and interpreting more genomes than any other company in the world. Knome is a privately held company. For more information, please visit www.knome.com.


'/>"/>
SOURCE Knome
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Knome Featured in New PBS Series Faces of America with Henry Louis Gates, Jr.
2. Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers
3. Scripps Announces Sale of United Medias Licensing Business for $175 Million
4. YM BioSciences announces controlled equity offering
5. MedQuist Announces Completion of Spheris Transaction
6. BIO-IT World Announces the Winners of its 2010 Best Practices Awards Program
7. Facet Solutions Announces 2 Year Data from US Pilot Study
8. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
9. Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home.
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , April 11, 2017 NXT-ID, Inc. ... technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate governance ... Gino ... we look forward to their guidance and benefiting from their ...
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
Breaking Biology News(10 mins):